Stocktoria

GLAUKOS Corp GKOS

NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2015-06-25

GLAUKOS Corp financials (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Revenue$507.4M$383.5M$314.7M$282.9M$294.0M
Gross profit$282.8M$289.5M$239.1M$213.9M$227.4M
SG&A expense$331.7M$261.2M$224.1M$192.9M$179.3M
Operating income-$199.6M-$122.4M-$128.7M-$82.3M-$32.9M
Interest expense$13.6M$13.7M$13.4M
Income tax-$5.4M$771,000$934,000$766,000$326,000
Net income-$187.7M-$146.4M-$134.7M-$99.2M-$49.6M
EPS (diluted)$-3.28$-2.77$-2.78$-2.09$-1.07
Operating cash flow-$14.8M-$61.3M-$57.8M-$33.1M$24.7M
Free cash flow-$22.5M-$67.6M-$78.0M-$63.3M-$23.1M
Cash & equivalents$90.8M$169.6M$93.5M$119.5M$100.7M
Inventory$63.6M$57.7M$42.0M$37.8M$23.0M
Total assets$893.5M$974.8M$940.4M$1.0B$1.0B
Total liabilities$237.3M$207.8M$478.6M$472.4M$462.5M
Shareholders' equity$656.2M$766.9M$461.8M$530.0M$587.2M

Source: SEC EDGAR filings · CIK 0001192448 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.